226 results on '"N. Ozbek"'
Search Results
2. Risk factors and outcomes related to intensive care unit admission of children with hematological and solid organ malignancies: single-center experience
- Author
-
C. Kaya, Z. Guzelkucuk, D. Ozyoruk, N. Ozbek, and N. Yarali
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
3. The effects of vitamin D deficiency on myocardial deformation and functions in patients with β-thalassemia
- Author
-
A. Koca Yozgat, E. Azak, D. Kaçar, M. Işık, O. Arman Bilir, I. Çetin, N. Ozbek, and N. Yaralı
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
4. Isolated extramedullary relapse after hematopoietic stem cell transplantation
- Author
-
Z. Guzelkucuk, P. Isık, O. Arman Bilir, D. Kacar, A. Koca Yozgat, M. Isık, D. Gurlek Gokcebay, I. Ok Bozkaya, N. Ozbek, and N. Yarali
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
5. Multiple relapsed acute lymphoblastic leukemia with t(9;13) in a child
- Author
-
D. Gurlek Gokcebay, Y. Akcabelen, A. Koca Yozgat, D. Kacar, O. Arman Bilir, M. Isik, I. Ok Bozkaya, N. Ozbek, and N. Yarali
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
6. Health-related quality of life for children with leukemia: child and parental perceptions
- Author
-
E. Ocak, A. Koca Yozgat, D. Kaçar, I. Ayrancı Sucaklı, N. Ozbek, O. Şükran Üneri, and H. Yaralı
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
7. A girl with SAMD9L mutation presenting with pancytopenia, immunodeficiency and myelodsyplasia
- Author
-
D. Gurlek Gokcebay, I. Yaman Bajin, Y. Akcabelen, A. Koca Yozgat, O. Arman Bilir, I. Ok Bozkaya, N. Yarali, and N. Ozbek
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
8. Drug Repurposing in the Treatment of COVID-19
- Author
-
M. Soylu, E. N. Ozbek, and Gunay Yetik-Anacak
- Subjects
Drug ,medicine.medical_specialty ,lcsh:R5-920 ,Coronavirus disease 2019 (COVID-19) ,Drug discovery ,business.industry ,media_common.quotation_subject ,General Engineering ,computer-based approaches ,drug repositioning ,Drug repositioning ,Clinical research ,Drug development ,covid-19 ,Pharmacovigilance ,medicine ,Intensive care medicine ,business ,lcsh:Medicine (General) ,Repurposing ,media_common - Abstract
The use of drugs that have been previously defined for certain indications in new indications is defined as the repurposing/repositioning of the drug. The requirement of all clinical research steps that starts from healthy volunteers, due to the slowness of new drug discovery, longer time to reach the market, and high cost to develop a new drug, make drug repurposing an attractive pharmacoeconomic solution. Repositioning of drugs becomes even more important, especially in situations where time is vital and emergency in drug development such as pandemics. In this review, we have both summarized the techniques used for drug repositioning and evaluated drugs that have been repositioned in Coronavirus Disease (COVID-19) treatment based on three main strategies, target-disease and drug-based. Considering the availability of the results of pharmacovigilance studies and long-term toxic effects of old drugs provide an important advantage compared to traditional drug discovery in COVID-19 treatment, where sepsis and multi-organ dysfunction can occur.
- Published
- 2020
9. Pneumatosis cystoides intestinalis: A rare complication after hematopoietic stem cell transplantation
- Author
-
Dilek Gürlek Gökçebay, İkbal Ok Bozkaya, Arzu Meltem Demir, N. Yarali, Altan Güneş, N. Ozbek, Yunus Murat Akçabelen, and Özlem Arman Bilir
- Subjects
Transplantation ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Perforation (oil well) ,Octreotide ,Hematopoietic stem cell transplantation ,Gastroenterology ,Peritoneal cavity ,surgical procedures, operative ,medicine.anatomical_structure ,Submucosa ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Pneumatosis Cystoides Intestinalis ,Conventional PCI ,medicine ,business ,Complication ,medicine.drug - Abstract
Background Pneumatosis cystoides intestinalis (PCI) is a disorder in which widespread air sacs are present in mucosa, submucosa, subserosa, and intraabdominal area of the intestinal wall. It has a heterogeneous clinical presentation as a rare complication of intestinal graft-versus-host disease (GVHD). Computed tomography is the preferred imaging method for the diagnosis. Since the air sacs could be ruptured spontaneously, the presence of free air in the peritoneal cavity does not confirm intestinal perforation. The conservative treatment approach is sufficient in cases that do not require urgent surgical intervention, such as perforation or obstruction. Case Here, we present a 2.5-year-old patient diagnosed with primary hemophagocytic lymphohistiocytosis (pHLH), who underwent allogeneic hematopoietic stem cell transplantation from a matched unrelated donor (MUD) and developed PCI secondary to intestinal GVHD 14th months after HSCT. Conclusions Pneumatosis cystoides intestinalis, which is a rare complication, should be kept in mind, especially in patients with intestinal GVHD and receiving intensive immunosuppressive, octreotide, and steroid treatment after HSCT.
- Published
- 2021
- Full Text
- View/download PDF
10. Multiple relapsed acute lymphoblastic leukemia with t(9;13) in a child
- Author
-
I. Ok Bozkaya, O. Arman Bilir, A. Koca Yozgat, Dilek Kaçar, Y. Akcabelen, D. Gurlek Gokcebay, N. Ozbek, N. Yarali, and Melek Işık
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,lcsh:RC633-647.5 ,Lymphoblastic Leukemia ,Internal medicine ,medicine ,Immunology and Allergy ,Hematology ,lcsh:Diseases of the blood and blood-forming organs ,business - Published
- 2020
11. The impact of pretreatment serum cobalamin and folate levels on complications and peripheral blood recovery during induction chemotherapy of leukemia: a cross-sectional study
- Author
-
Hüsniye Neşe Yaralı, N. Ozbek, Özlem Arman Bilir, Abdurrahman Kara, and Volkan Köse
- Subjects
Vitamin ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Gastroenterology ,Cobalamin ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Folic Acid ,Internal medicine ,medicine ,Humans ,Platelet ,030212 general & internal medicine ,Vitamin B12 ,Child ,Retrospective Studies ,Chemotherapy ,business.industry ,Induction chemotherapy ,Induction Chemotherapy ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,medicine.disease ,Leukemia ,Vitamin B 12 ,Cross-Sectional Studies ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Female ,Complication ,business - Abstract
We aimed to evaluate the impact of pretreatment folate and vitamin B12 deficiencies on the frequency of complications and peripheral blood recovery, in children with acute lymphoblastic leukemia (ALL). Pre-induction serum folate and vitamin B12 levels of 88 newly diagnosed ALL patients were evaluated retrospectively. Folate 1.0 × 109/L and platelet count > 100 × 109/L at 33rd day of chemotherapy were also evaluated. Folate or vitamin B12 deficiencies were observed in 21 (23%) and 40 (45%) children, respectively. Peripheral blood counts, complications rates, and transfusion needs were not statistically different between deficient and normal level groups during induction. The number of febrile days, though not statistically significant, was higher in the both deficient groups. Seventeen of 40 (42.5%) patients with vitamin B12-deficient and 12 of 21 (57.1%) folate-deficient patients experienced at least one episode of FN during induction. FN was more common in folate-deficient group, but that was not statistically significant. Complete peripheral blood recovery at 33rd day of induction was seen in 40% in the vitamin B12-deficient group and 28.6% in folate-deficient group. Peripheral blood recovery rate at day 33 was also similar in both deficient and normal level groups. Although pre-induction low serum levels of vitamin B12 and folate did not have statistically significant impact on disease-/treatment-related complications and peripheral blood recovery at induction, the frequency of FN and number of febrile day were higher in both deficiencies and folate-deficient patients, respectively.
- Published
- 2020
12. Oral Healthcare Measures to Improve Overall Health in Older Adults
- Author
-
Uloma Onubogu, W. Michael Mansfield, and Irene N. Ozbek
- Subjects
Gerontology ,stomatognathic diseases ,business.industry ,Health care ,Medicine ,business - Abstract
The purpose of this paper is to guide the understanding of preventive oral health measures to improve overall health in older adults. Oral health is a key indicator of overall health, well-being, and quality of life, yet, oral health status among older adults has remained alarmingly poor. Common oral conditions include dental decay, periodontal disease, tooth loss, dry mouth, and malodor. The connection between oral and systemic health has been established and this relationship is affected by various interrelated factors which pose many threats to older adults’ health. Documented factors may range from chronic diseases, use of medications, individual lifestyle, decline in cognitive and physical functioning, access to care, to several social indicators of oral health. Dental disease and poor oral health are largely preventable through healthy lifestyle behaviors and effective management of chronic systemic diseases. A collaborative team approach is necessary to ensure that older adults receive comprehensive care appropriate for their complex medical and dental needs.
- Published
- 2019
- Full Text
- View/download PDF
13. Isolated extramedullary relapse after hematopoietic stem cell transplantation
- Author
-
D. Gurlek Gokcebay, N. Ozbek, Neşe Yaralı, Pamir Isik, I. Ok Bozkaya, Zeliha Guzelkucuk, A. Koca Yozgat, Melek Işık, O. Arman Bilir, and Dilek Kaçar
- Subjects
lcsh:RC633-647.5 ,business.industry ,medicine.medical_treatment ,Cancer research ,Immunology and Allergy ,Medicine ,lcsh:Diseases of the blood and blood-forming organs ,Hematology ,Hematopoietic stem cell transplantation ,business - Published
- 2020
- Full Text
- View/download PDF
14. Neuro-ichthyotic Syndromes: A Case Series
- Author
-
Faruk, Incecık, Ozlem M, Herguner, Mehmet N, Ozbek, Serdal, Gungor, Mustafa, Yılmaz, Wiliam B, Rizzo, and Gülen G, Mert
- Subjects
Original Article ,neuro-ichthyotic diseases ,skin and physical examination ,Genetic study - Abstract
Background: The neuro-ichthyotic diseases are clinically and genetically heterogeneous. The purpose of this study was to evaluate the clinical and neuroradiological findings and to analyze mutation in 15 patients with neuro-ichthyotic diseases. Materials and Methods: We retrospectively analyzed the records of 15 patients with the diagnosis of neuro-ichthyotic diseases. Results: Eight female and seven male patients (age range 11 months–52 years) were investigated. There were eight patients with Sjögren–Larsson syndrome (SLS), five patients with multiple sulfatase deficiency (MSD), one patient with Chanarin–Dorfman's syndrome, and one patient with mental retardation, enteropathy, deafness, neuropathy, ichthyosis, and keratodermia (MEDNIK) syndrome. Parental consanguinity was found in all the patients except one. All patients had ichthyosis. Diagnosis was performed with genetic study. Conclusions: Because biochemical and clinical findings are variable, the diagnosis is difficult in most of the cases. Detailed skin and physical examinations are mandatory in these patients. Genetic tests are necessary for accurate diagnosis.
- Published
- 2018
15. PF183 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CHILDREN WITH HEMATOLOGHIC AND ONCOLOGIC DISEASES: MULTICENTER EXPERIENCE
- Author
-
Melike Sezgin Evim, N. Ozbek, Gürcan Dikme, Baris Malbora, Sema Vural, Özlem Tüfekçi, O. Arman Bilir, Z. OnderSivis, Tiraje Celkan, Turan Bayhan, Serhat Karaman, and Aysenur Bahadir
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,medicine ,Posterior reversible encephalopathy syndrome ,Hematology ,medicine.disease ,business - Published
- 2019
- Full Text
- View/download PDF
16. Clinical comparison of weight- and age-based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation
- Author
-
Betul Tavil, Bahattin Tunç, N. Ozbek, D. Gürlek Gökçebay, Zekai Avci, Fatih Mehmet Azik, Ateş Kara, and Pamir Isik
- Subjects
Male ,medicine.medical_specialty ,Neutropenia ,Transplantation Conditioning ,Adolescent ,Fever ,medicine.medical_treatment ,Graft vs Host Disease ,Engraftment Syndrome ,Hematopoietic stem cell transplantation ,Recurrence ,Internal medicine ,medicine ,Humans ,Dosing ,Child ,Infusions, Intravenous ,Busulfan ,Cyclophosphamide ,Retrospective Studies ,Transplantation ,Hematology ,business.industry ,Incidence (epidemiology) ,Body Weight ,Graft Survival ,Age Factors ,Hematopoietic Stem Cell Transplantation ,Infant ,medicine.disease ,Hematologic Diseases ,Surgery ,Treatment Outcome ,surgical procedures, operative ,Child, Preschool ,Hematologic Neoplasms ,Multivariate Analysis ,Pediatrics, Perinatology and Child Health ,Female ,business ,Hemorrhagic cystitis ,medicine.drug - Abstract
Bu, combined with TDM-guided dosing, is associated with fewer graft failures/relapses and lower toxicity in pediatric HSCT. We aimed this retrospective study for comparison of weight- and age-based dosing in terms of clinical outcomes such as time to engraftment, early complications, EFS, OS, and toxicity profiles in children receiving iv Bu. Sixty-one children who underwent HSCT from April 2010 to February 2013 by means of a Bu-based conditioning regimen and completed 100 days after transplantation at Ankara Children?s Hematology and Oncology Hospital Bone Marrow Transplantation Unit were enrolled in this study. SOS and neutropenic fever occurred more frequently in the weight-based dosing group. We found a statistically significant correlation between Bu dose and the incidence of SOS (r = 0.26, p = 0.04). Multivariate analysis showed only weight-based dosing of Bu was a significant predictor of SOS (HR = 9.46; p = 0.009). However, no relationship was found between two groups in terms of hemorrhagic cystitis, engraftment syndrome, acute or chronic GvHD, time to engraftment, chimerism, TRM, OS, and EFS rates. Weight-based dosing of Bu may cause higher incidence of SOS and early infectious complications at the places where TDM of Bu cannot be performed.
- Published
- 2015
- Full Text
- View/download PDF
17. PB2274 PROPHYLAXIS ADHERENCE RELATIVE TO QUALITY OF LIFE AND ANXIETY LEVEL IN TURKISH PATIENTS WITH SEVERE HEMOPHILIA A
- Author
-
T. Gursel, M. Albayrak, C. Muluk, E. Güney, Z. Kaya, N. Ozbek, S. Aytac, and N. İsmayılova
- Subjects
Pediatrics ,medicine.medical_specialty ,Anxiety level ,Quality of life (healthcare) ,business.industry ,Turkish ,medicine ,language ,Hematology ,business ,Severe hemophilia A ,language.human_language - Published
- 2019
- Full Text
- View/download PDF
18. Poster Session 2: Thursday 8 December 2011, 14:00-18:00 * Location: Poster Area
- Author
-
X. Luo, F. Fang, J. Sun, J. Xie, A. Lee, Q. Zhang, C. Yu, O. Breithardt, S. Schiessl, M. Schmid, M. Seltmann, L. Klinghammer, C. Zeissler, M. Kuechle, W. Daniel, M. Ege, U. Guray, Y. Guray, B. Demirkan, H. Kisacik, S.-E. Kim, J.-Y. Hong, J.-H. Lee, D.-G. Park, K.-R. Han, D.-J. Oh, O. Tufekcioglu, D. C. Cozma, C. Mornos, A. Ionac, L. Petrescu, C. Tutuianu, S. I. Dragulescu, L. Guimaraes, G. Tavares, A. Rodrigues, C. Nagamatsu, C. Fischer, M. Vieira, W. Oliveira, T. Wilberg, A. Cordovil, S. Morhy, D. Muraru, M. Peluso, L. Dal Bianco, M. Beraldo, E. Solda', M. Tuveri, U. Cucchini, A. Al Mamary, L. Badano, S. Iliceto, A. Pizzuti, B. Mabritto, C. Derosa, A. Tomasello, M. Rovere, I. Parrini, M. Conte, N. Lareva, A. Govorin, R. Cooper, J. Sharif, J. D. Somauroo, J. D. Hung, V. Porcelli, R. Skevington, A. Shahzad, S. Scott, P. Lindqvist, S. Soderberg, M. Gonzalez, E. Tossavainen, M. Henein, N. Nciri, H. Saad, S. Nawas, A. Ali, A. Youssufzay, A. Safi, S. Faruk, S. Yurdakul, V. Erdemir, Y. Tayyareci, O. Yildirimturk, K. Memic, V. Aytekin, M. Gurel, S. Aytekin, M. Przewlocka-Kosmala, M. Cielecka-Prynda, A. Mysiak, W. Kosmala, S. Pescariu, D. Cozma, A. Mornos, S. Dragulescu, N. Maurea, C. G. Tocchetti, C. Coppola, C. Quintavalle, D. Rea, A. Barbieri, G. Piscopo, C. Arra, G. Condorelli, R. Iaffaioli, H. Dalen, A. Thorstensen, H. Moelmen, H. Torp, A. Stoylen, D. Augustine, C. Basagiannis, J. Suttie, P. Cox, R. Aitzaz, A. Lewandowski, M. Lazdam, C. Holloway, H. Becher, P. Leeson, S. Radovanovic, A. Djokovic, B. Todic, M. Zdravkovic, M. Zaja-Simic, S. Banicevic, D. Lisulov-Popovic, M. Krotin, J. Grapsa, D. O'regan, D. Dawson, G. Durighel, L. Howard, J. Gibbs, P. Nihoyannopoulos, C. Tulunay Kaya, M. Kilickap, H. Kurklu, N. Ozbek, C. Koca, V. Kozluca, K. Esenboga, C. Erol, B. Kusmierczyk-Droszcz, E. Kowalik, J. Niewiadomska, P. Hoffman, M. Satendra, L. Sargento, S. Lopes, S. Longo, N. Lousada, R. Palma Reis, P. Chillo, A. Rieck, J. Lwakatare, J. Lutale, E. Gerdts, S. Bonapace, G. Molon, G. Targher, A. Rossi, L. Lanzoni, G. Canali, E. Campopiano, L. Zenari, L. Bertolini, E. Barbieri, K. Hristova, L. Vladiomirova-Kitova, T. Katova, F. Nikolov, P. Nikolov, S. Georgieva, I. Simova, V. Kostova, V. A. Kuznetsov, D. V. Krinochkin, P. A. Chandraratna, Y. A. Pak, E. H. Zakharova, A. V. Plusnin, M. V. Semukhin, E. A. Gorbatenko, E. I. Yaroslavskaya, G. Bedetti, L. Gargani, M. Scalese, C. Pizzi, R. Sicari, E. Picano, M. Reali, E. Canali, S. Cimino, M. Francone, M. Mancone, R. Scardala, F. Boccalini, Y. Hiramoto, A. Frustaci, L. Agati, K. Savino, A. Lilli, E. Bordoni, C. Riccini, G. Ambrosio, D. Silva, N. Cortez-Dias, P. Carrilho-Ferreira, C. Jorge, J. Silva-Marques, A. Magalhaes, L. Santos, S. Ribeiro, F. Pinto, A. Nunes Diogo, E. Kinova, N. Zlatareva, A. Goudev, C. Bonanad, M. Lopez-Lereu, J. Monmeneu, V. Bodi, J. Sanchis, J. Nunez, F. Chaustre, A. Llacer, D. Ermacora, D. Peluso, M. Di Lazzari, P. Meimoun, F. Elmkies, T. Benali, J. Boulanger, H. Zemir, J. Clerc, A. Luycx-Bore, M. S. Velasco Del Castillo, A. Cacicedo Fernandez De Bobadilla, J. Onaindia Gandarias, M. Telleria Arrieta, G. Zugazabeitia Irazabal, O. Quintana Raczka, I. Rodriguez Sanchez, A. Romero Pereiro, E. Laraudogoitia Zaldumbide, I. Lekuona Goya, B. Bonello, E. El Louali, V. Fouilloux, I. Kammache, C. Ovaert, B. Kreitmann, A. Fraisse, R. Migliore, M. Adaniya, M. Barranco, G. Miramont, H. Tamagusuku, A. Alassar, R. Sharma, A. Marciniak, O. Valencia, N. Abdulkareem, M. Jahangiri, N. Jander, R. Kienzle, C. Gohlke-Baerwolf, H. Gohlke, F.-J. Neumann, J. Minners, S. Valbuena, F. De Torres, T. Lopez, J. J. Gomez, G. Guzman, F. Dominguez, E. Refoyo, M. Moreno, J. L. Lopez-Sendon, R. Ancona, S. Comenale Pinto, P. Caso, G. Di Salvo, S. Severino, M. Cavallaro, R. Calabro, R. Enache, R. Piazza, A. Roman-Pognuz, B. Popescu, A. Calin, C. Beladan, F. Purcarea, G. Nicolosi, C. Ginghina, O. Savu, M. Rosca, R. Jurcut, M. Serban, L. Dorobantu, E. Donal, S. Mascle, C. Thebault, D. Veillard, H. Hamonic, A. Leguerrier, H. Corbineau, B. A. Popa, M. Diena, A. Bogdan, D. Benea, G. Lanzillo, V. Casati, E. Novelli, A. Popa, G. Cerin, F. Gual Capllonch, A. Teis, J. Lopez Ayerbe, E. Ferrer, N. Vallejo, E. Gomez Denia, A. Bayes Genis, S. Spethmann, S. Schattke, G. Baldenhofer, V. Stangl, M. Laule, G. Baumann, K. Stangl, F. Knebel, C. Labata, C. Garcia Alonso, F. Gual, R. Nunez Aragon, C. Sousa, A. I. Vasile, M. Dorobantu, C. Iorgulescu, S. Bogdan, D. Constantinescu, C. Caldararu, O. Tautu, R. Vatasescu, H. Badran, M. F. Elnoamany, M. Ayad, A. Elshereef, A. Farhan, Y. Nassar, M. Yacoub, J. Costabel, G. Avegliano, P. Elissamburu, J. Thierer, F. Castro, M. Huguet, A. Frangi, R. Ronderos, C. Prinz, F. Van Buuren, L. Faber, T. Bitter, N. Bogunovic, W. Burchert, D. Horstkotte, J. D. Kasprzak, A. Smialowski, T. Rudzinski, P. Lipiec, M. Krzeminska-Pakula, K. Wierzbowska-Drabik, E. Trzos, M. Kurpesa, H. Motoki, M. Hana, T. Marwick, K. Allan, M. Vazquez-Alvarez, C. Medrano Lopez, S. Granja Da Silva, C. Marcos, A. Rodriguez-Ogando, M. Alvarez, M. Camino, M. Centeno, E. Maroto, G. Feltes Guzman, V. Serra Tomas, O. Acevedo, A. Calli, M. Barba, G. Pintos, V. Valverde, J. Zamorano Gomez, M. Marchel, J. Kochanowski, R. Piatkowski, A. Madej, K. Filipiak, I. Hausmanowa-Petrusewicz, G. Opolski, E. Malev, E. Zemtsovsky, S. Reeva, E. Timofeev, A. Pshepiy, S. Mihaila, R. Rimbas, R. Mincu, R. Dulgheru, R. Mihaila, C. Badiu, M. Cinteza, D. Vinereanu, E. Lira, D. Lebihan, C. Monaco, M. Ruiz Ortiz, D. Mesa, M. Delgado, E. Romo, M. Pena, M. Puentes, M. Santisteban, A. Lopez Granados, J. Arizon Del Prado, J. Suarez De Lezo, W.-C. Tsai, J.-Y. Shih, T.-S. Huang, Y.-W. Liu, Y.-Y. Huang, L.-M. Tsai, E. Cho, K. Choi, B. Kwon, D. Kim, S. Jang, C. Park, H. Jung, H. Jeon, H. Youn, J. Kim, A. E. Rieck, D. Cramariuc, M. Lonnebakken, B. Lund, P. Moceri, D. Doyen, P. Cerboni, E. Ferrari, W. Li, S. Goncalves, G. Vinhais De Sousa, A. G. Almeida, C. Hernandez Garcia, A. De La Rosa Hernandez, E. Arroyo Ucar, P. Jorge Perez, A. Barragan Acea, J. Lacalzada Almeida, J. Jimenez Rivera, A. Duque Garcia, I. Laynez Cerdena, O. Arhipov, A. N. Sumin, L. Campens, M. Renard, B. Trachet, P. Segers, A. De Paepe, J. De Backer, J. A. Purvis, D. Sharma, S. M. Hughes, D. Marek, D. Vindis, E. Kocianova, M. Taborsky, H. Yoon, K. Kim, Y. Ahn, M. Chung, J. Cho, J. Kang, W. Rha, O. Ozcan, D. Sezgin Ozcan, B. Candemir, M. Aras, I. Dincer, R. Atak, L. Gianturco, M. Turiel, F. Atzeni, L. Tomasoni, E. Bruschi, O. Epis, P. Sarzi-Puttini, C. Aggeli, E. Poulidakis, I. Felekos, S. Sideris, P. Dilaveris, K. Gatzoulis, C. Stefanadis, N. Roszczyk, M. Sobczak, J. Peruga, R. Krecki, J. Kasprzak, K. Ishii, T. Suyama, K. Kataoka, A. Furukawa, T. Nagai, M. Maenaka, Y. Seino, F. Musca, B. De Chiara, A. Moreo, S. Cataldo, M. Parolini, O. Parodi, T. Bombardini, F. Faita, S.-J. Park, J.-H. Kil, S.-J. Kim, S.-Y. Jang, S.-A. Chang, J.-O. Choi, S.-C. Lee, S. Park, P. Park, J. Oh, M. Cikes, V. Velagic, B. Biocina, H. Gasparovic, Z. Djuric, B. Bijnens, D. Milicic, A. Huqi, B. Klas, A. He, I. Paterson, M. Irween, J. Ezekovitz, J. Choy, Y. Chen, L. Cheng, R. Yao, H. Yao, H. Chen, C. Pan, X. Shu, B. Sobkowicz, M. Kaminska, W. Musial, R. Buechel, G. Sommer, G. Leibundgut, A. Rohner, J. Bremerich, B. Kaufmann, A. Kessel-Schaefer, M. Handke, A. Kiotsekoglou, S. Saha, R. Toole, S. Sharma, A. Gopal, S. Adhya, W. Tsang, C. Kenny, S. Kapetanakis, R. Lang, M. Monaghan, B. Smith, T. Coulter, A. Rendon, W.-S. Cheung, W. Gorissen, J. A. Ejlersen, O. May, F. J. Van Slochteren, T. Van Der Spoel, H. Hanssen, P. Doevendans, S. Chamuleau, C. De Korte, A. Tarr, S. Stoebe, T. Trache, J.-G. Kluge, A. Varga, A. Hagendorff, A. Nagy, A. Kovacs, A. Apor, B. Sax, D. Becker, B. Merkely, R. Lindquist, A. Miller, C. Reece, B. W. Eidem, W.-G. Choi, S. Kim, S. Oh, Y. Kim, R. Iacobelli, M. Chinali, M. D' Asaro, A. Toscano, A. Del Pasqua, C. Esposito, G. Seghetti, F. Parisi, G. Pongiglione, G. Rinelli, O. Omaygenc, R. Bakal, C. Dogan, K. Teber, S. Akpinar, G. Sahin, N. Ozdemir, A. Penhall, M. Joseph, F. Chong, C. De Pasquale, J. Selvanayagam, D. Leong, E. G. Nyktari, A. P. Patrianakos, C. Goudis, G. Solidakis, F. Parthenakis, P. Vardas, E. Nestaas, D. Fugelseth, A. Vitarelli, L. Capotosto, M. Bernardi, Y. Conde, F. Caranci, G. Placanica, O. Dettori, M. Vitarelli, S. De Chiara, V. De Cicco, M. Ferro', R. Calabro', S. Apostolakis, G. Chalikias, D. Tziakas, D. Stakos, A. Thomaidi, S. Konstantinides, G. Iorio, R. Rucos, G. Continanza, M. D Ascanio, L. Alessandroni, M. Saponara, M. Berry, J. Nahum, O. Zaghden, J. Monin, J. Couetil, O. Lairez, L. Macron, J. Dubois Rande, P. Gueret, P. Lim, M. Cameli, E. Giacomin, M. Lisi, S. Benincasa, F. Righini, D. Menci, M. Focardi, S. Mondillo, E. Philip, G. Gorincour, H. Bellsham-Revell, A. J. Bell, O. I. Miller, P. Beerbaum, R. Razavi, G. Greil, J. M. Simpson, S. Ann, T. Kim, J. Lee, J. Chin, P. Cabeza Lainez, V. Escolar Camas, L. Gheorghe, P. Fernandez Garcia, R. Vazquez Garcia, V. Caiulo, S. Caiulo, A. Fisicaro, F. Moramarco, G. Latini, A. Seale, J. Carvalho, H. Gardiner, M. Roughton, J. Simpson, A. Tometzki, O. Uzun, S. Webber, P. Daubeney, A. Dawood, G. Dwivedi, G. Mahadevan, D. Jiminez, R. Steeds, M. Frenneaux, C. H. Attenhofer Jost, B. Knechtle, A. Bernheim, M. Pfyffer, A. Linka, A. Faeh-Gunz, B. Seifert, G. De Pasquale, M. Zuber, A. Tomaszewski, A. Kutarski, and M. Tomaszewski
- Subjects
Computer science ,Plane (geometry) ,business.industry ,Echo (computing) ,Left atrium ,General Medicine ,Biplane ,medicine.anatomical_structure ,Software ,Left atrial ,medicine ,Radiology, Nuclear Medicine and imaging ,Cardiology and Cardiovascular Medicine ,business ,Nuclear medicine - Published
- 2011
- Full Text
- View/download PDF
19. Mutational analysis of the galactose-1-phosphate uridyltransferase (GALT) gene in southeast part of Turkey: a regional report
- Author
-
M, Akar, M, Celik, C S, Kasapkara, M N, Ozbek, B, Aldudak, and H, Tuzun
- Subjects
Galactosemias ,Consanguinity ,Turkey ,Mutation ,Infant, Newborn ,Humans ,UTP-Hexose-1-Phosphate Uridylyltransferase ,Infant, Newborn, Diseases - Published
- 2015
20. Metastasis to the Pituitary Gland From Lung Cancer
- Author
-
Meftun Unsal, Cengiz Cokluk, Hande Türker, and Nilg n Ozbek Okumus
- Subjects
Oncology ,medicine.medical_specialty ,Pituitary gland ,Left lung ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Magnetic resonance imaging ,medicine.disease ,Metastasis ,Radiation therapy ,medicine.anatomical_structure ,Sella turcica ,Internal medicine ,medicine ,Adenocarcinoma ,Surgery ,Neurology (clinical) ,Radiology ,Lung cancer ,business - Abstract
Lung cancer metastasis to the pituitary gland is an unusual pathology. In this report, we present a 63-year-old woman with pituitary gland mass due to lung cancer metastasis. The patient was admitted to our hospital because of difficulty of vision. She had a lung cancer diagnosis (adenocarcinoma) and had an operation for a mass in the left lung. There was no problem with her follow-up except vision difficulty that was noted in her last examination. Cranial magnetic resonance imaging revealed a pituitary mass in her sella turcica. The magnetic resonance imaging also showed left frontal metastatic mass. Radiotherapy was performed but failed, and the mass lesion was found to have progressed. The patient died 3 months after the diagnosis of metastasis was established. This case represents a rare report in the literature. Pituitary metastases may rarely be seen in the late stages of lung cancer and are even more rare in women. Clinical characteristics generally resemble the other hormonally unfunctional pituitary masses. Radiotherapy may not be as effective as for the other cranial metastases.
- Published
- 2007
- Full Text
- View/download PDF
21. Recognition of Depression
- Author
-
Terry A. Melvin, I. N. Ozbek, and D. E. Eberle
- Subjects
Adult ,medicine.medical_specialty ,Terminally ill ,050109 social psychology ,Severity of Illness Index ,Surveys and Questionnaires ,medicine ,Humans ,0501 psychology and cognitive sciences ,Psychiatry ,Depression (differential diagnoses) ,Aged ,Aged, 80 and over ,Psychiatric Status Rating Scales ,Depressive Disorder ,business.industry ,Incidence ,Health Policy ,Incidence (epidemiology) ,05 social sciences ,Public Health, Environmental and Occupational Health ,Reproducibility of Results ,050301 education ,Middle Aged ,Hospice Care ,Mood ,Geriatric Depression Scale ,Karnofsky score ,business ,0503 education - Abstract
Depression in the terminally ill has never been examined systematically. Frequently depression has been perceived as an inevitable part of illness. The purpose of the present study was to develop an instrument (the Mood Evaluation Questionnaire) to measure depression among terminally ill patients. The MEQ and the Geriatric Depression Scale were completed by 27 hospice patients. A Modified Karnofsky score and index of somatic complaints were obtained. There was no correlation among the Modified Karnofsky, the number of somatic complaints, and the level of depression. However the MEQ and GDS were highly correlated (p
- Published
- 1995
- Full Text
- View/download PDF
22. Internal Carotid Artery Occlusion in a Patient With Malignant Peritoneal Mesothelioma: Is It a Sign of Malignancy-Related Thrombosis?
- Author
-
Y, Ustündağ, U, Can, S, Benli, Y, Büyükasik, and N, Ozbek
- Subjects
Adult ,Male ,Mesothelioma ,Thrombocytosis ,Platelet Aggregation ,General Medicine ,Magnetic Resonance Imaging ,Radiography ,Risk Factors ,Splenectomy ,Humans ,Carotid Artery Thrombosis ,Carotid Artery, Internal ,Peritoneal Neoplasms - Abstract
To our knowledge, the occlusion of arteries and platelet hyperaggregation have not been reported in patients with malignant mesothelioma. However, venous thromboembolism, especially in the pulmonary vasculature in association with thrombocytosis and hyperfibrinogenemia, are commonly noticed in this disorder. Furthermore, we detected enhanced platelet aggregation in a case of malignant peritoneal mesothelioma with internal carotid artery occlusion in whom there were postsplenectomy thrombocytosis and hyperfibrinogenemia. The possible mechanisms of ICA occlusion in this patient, including the role of MPM and postsplenectomy state, thrombocytosis, platelet functional changes, and other factors were investigated and discussed.
- Published
- 2000
- Full Text
- View/download PDF
23. Prognostic significance of seizure in patients with glioblastoma multiforme
- Author
-
N, Ozbek, S, Cakir, B, Gursel, and D, Meydan
- Subjects
Adult ,Aged, 80 and over ,Male ,Age Factors ,Dose-Response Relationship, Radiation ,Middle Aged ,Prognosis ,Radiation Dosage ,Combined Modality Therapy ,Neurosurgical Procedures ,Central Nervous System Neoplasms ,Sex Factors ,Seizures ,Humans ,Female ,Glioblastoma ,Aged - Abstract
Several prognostic factors have been described but there are few studies evaluating the prognostic importance of seizure in patients with glioblastoma multiforme (GBM).To evaluate the prognostic importance of seizure at the time of the diagnosis of glioblastoma multiforme (GBM) and compare it with other known prognostic factors.Between January 1994 and December 2000, 81 patients underwent irradiation for intracranial GBM at our institution. The criteria for inclusion in this study were biopsy-proven GBM, being treated for primary disease. Seventy-six patients were retrospectively evaluated and the remaining five patients could not be enrolled due to lack of details.The prognostic importance of age, sex, performance status, a history of seizure at diagnosis, extent of surgery, radiotherapy field and dose were studied.The Kaplan-Meier method, the Log rank test, the Cox proportional hazard model and the Mann-Whitney U test were used for statistical analysis.Survival at first and second years was 19.74% and 4.81%, respectively. Univariate analysis revealed age, performance status, history of seizure, and radiotherapy dose as significant prognostic factors and with multivariate analysis age, history of seizure and radiotherapy dose were positive prognostic factors.This study concluded that in GBM, history of seizure prior to diagnosis of GBM was a positive prognostic factor.
- Published
- 2004
24. Significant differences between capillary and venous complete blood counts in the neonatal period
- Author
-
S M, Kayiran, N, Ozbek, M, Turan, and B, Gürakan
- Subjects
Male ,Hemoglobins ,Blood Cells ,Age Factors ,Infant, Newborn ,Humans ,Female ,Blood Cell Count ,Capillaries ,Veins - Abstract
The normal capillary and venous hematologic values for neonates have not been defined clearly. It is well known that capillary blood has higher hemoglobin (Hb) and hematocrit (Hct) values than venous blood. In a recent study, we reported differences between capillary and venous complete blood counts (CBC) in healthy term neonates on day 1 of life. The aim of this study was to extend our previous investigation. Term neonates (n=141) were stratified into four groups by days of postnatal age: group 2 (day 7, n=38), group 3 (day 14, n=35), group 4 (day 21, n=32) and, group 5 (day 28, n=36). Data from our previous study were included in the statistical analysis as group 1 (day 1, n=95). A CBC and differential count were carried out on each capillary and venous sample drawn simultaneously. Within each group, the mean and standard deviation for each parameter in capillary and venous blood were calculated and then compared using the paired sample t-test. In all groups, the capillary blood samples had higher Hb, Hct, red blood cell (RBC), white blood cell (WBC), and lymphocyte counts. In each group, venous platelet counts were significantly higher than the corresponding capillary values. There was also a trend toward higher venous mean corpuscular volume, higher capillary polymorphonuclear leukocyte (PML) count and mean platelet volume in all groups. In both capillary and venous blood, Hb, Hct, RBC, MCV values and WBC, lymphocyte, PML counts decreased and platelet counts increased steadily during neonatal period. This study reveals that CBC parameters and differential counts may differ depending on the blood sampling used. The findings underline the importance of considering the sample source when using hematologic reference ranges for healthy or septic neonates. When interpreting results, the term 'peripheral blood' should be replaced with 'capillary blood' or 'venous blood' so that an accurate assessment can be made.
- Published
- 2003
25. Activated protein C resistance and false type 2 protein C deficiency detected after multiple shunt failures in a patient with hydrocephalus
- Author
-
S M, Kayiran, N, Ozbek, H, Caner, K, Tokel, S, Mercan, and F, Alehan
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Heart Diseases ,Protein C deficiency ,medicine ,Humans ,In patient ,False Positive Reactions ,Heart Atria ,Thrombus ,Activated Protein C Resistance ,business.industry ,Thrombosis ,Protein C Activity ,medicine.disease ,Cerebrospinal Fluid Shunts ,Hydrocephalus ,medicine.anatomical_structure ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Right atrium ,Equipment Failure ,Neurology (clinical) ,Blood Coagulation Tests ,Activated protein C resistance ,business ,Carrier Proteins ,Shunt (electrical) - Abstract
A 2-year-old hydrocephalic boy who had suffered multiple shunt failures was evaluated for hypercoagulability after a thrombus was removed from his right atrium. The work-up revealed that the patient had the heterozygous form of activated protein C resistance and false type 2 protein C deficiency by the clotting method. His protein C activity was normal by the chromogenic method. We suggest that patients having hydrocephalus, shunt-associated thrombus formation, or both should be evaluated for thrombophilic disorders, and protein C activity should be measured by chromogenic assay in patients with documented activated protein C resistance. ( J Child Neurol 2001; 16:862-863).
- Published
- 2001
26. Fatal acidosis in a neonate with Pearson syndrome
- Author
-
B, Gürakan, N, Ozbek, B, Varan, and B, Demirhan
- Subjects
Fatal Outcome ,Liver ,Iron ,Infant, Newborn ,Humans ,Muscle Hypotonia ,Acidosis, Lactic ,Bone Marrow Cells ,Female ,Syndrome ,DNA, Mitochondrial ,Hypoglycemia - Abstract
We report a neonate who presented with hypotonia, hypoglycemia, and severe lactic acidosis. The patient's acidosis did not respond to bicarbonate replacement and dialysis. Postmortem liver samples revealed portal dilatation, fibrosis, canalicular proliferation, cholestasis, and hepatocellular hemosiderosis. Vacuolization of bone marrow precursors suggested a diagnosis of Pearson syndrome. A common mitochondrial DNA deletion of 4,978 bp was found. We emphasize that Pearson syndrome should be considered in neonates with lactic acidosis despite absence of anemia.
- Published
- 2000
27. Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia
- Author
-
S, Yetgin and N, Ozbek
- Subjects
Male ,Neutropenia ,Neutrophils ,Child, Preschool ,Chronic Disease ,Granulocyte Colony-Stimulating Factor ,Humans ,Cell Count ,Recombinant Proteins - Abstract
Chronic neutropenia in childhood has many definable causes and thus a clear cause cannot be identified in a large group of patients. Since the committed stem cell is involved in this disorder, growth factors such as granulocyte colony-stimulating factor (G-CSF) may play an important role in the treatment of severely affected children. Because of the side effects and cost, the use of G-CSF should be restricted to a minimum dose. Here we report a child with chronic neutropenia in whom intermittent-low doses of G-CSF were successfully used over a long period.
- Published
- 1998
28. High-dose methylprednisolone-induced dramatic maturation of granulocytes in idiopathic chronic neutropenia
- Author
-
S, Yetgin and N, Ozbek
- Subjects
Male ,Leukocyte Count ,Neutropenia ,Dose-Response Relationship, Drug ,Child, Preschool ,Chronic Disease ,Anti-Inflammatory Agents ,Humans ,Drug Monitoring ,Methylprednisolone ,Granulocytes - Abstract
Idiopathic chronic neutropenia is characterized by a variable pattern of age at the onset of neutropenia, neutrophil counts, maturational arrest at the promyelocyte/myelocyte stage in the bone marrow, and recurrent pyogenic infections without any underlying disease or drug administration. There have been reports of lack of response to conventional-dose steroid therapy, but in recent studies it has been shown that high-dose corticosteroids are effective in several neutropenic states. Here we report an apparent response to high-dose methylprednisolone in a patient with idiopathic chronic neutropenia.
- Published
- 1997
29. Spontaneous complete remission in a child with acute lymphoblastic leukemia
- Author
-
S, Yetgin, A M, Tuncer, E, Güler, and N, Ozbek
- Subjects
Child, Preschool ,Remission, Spontaneous ,Humans ,Blood Transfusion ,Female ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,Anti-Bacterial Agents - Abstract
A five-year-old girl was admitted to the hospital with fever and tender lymphadenopathy. She was diagnosed with acute lymphoblastic leukemia (ALL-L3). Because of infection she was given antibiotics and a blood transfusion. Her bone marrow was in remission after 15 days without chemotherapy. This case emphases the role of transfusion and/ or infection in obtaining complete remission without chemotherapy.
- Published
- 1996
30. Treatment of hemophilic pseudotumor with low-dose radiotherapy
- Author
-
N, Ozbek, M, Unsal, A, Kara, F, Gumruk, and A, Gurgey
- Subjects
Male ,Hematoma ,Adolescent ,Tibia ,Humans ,Bone Diseases ,Hemophilia A ,Radiation Dosage - Abstract
Hemophilic pseudotumor is one of the most serious complications of hemophilia and is usually treated with extensive surgery. A new treatment approach is radiotherapy. Patients with long-bone pseudotumors are usually treated with high doses of radiotherapy greater than 1500 cGy. We treated a 13-year-old hemophilic boy who had a pseudotumor of the tibia with low-dose radiotherapy (600 cGy). There was no complication during the two-and-a-half-year follow-up. Improvement of both the clinical and radiological status of the patient was noteworthy. We would like to suggest the use of low-dose radiotherapy in patients with hemophilic pseudotumors.
- Published
- 1996
31. Bernard-Soulier-like functional platelet defect in myelodysplastic syndrome and in acute myeloblastic leukemia associated with trilineage myelodysplasia
- Author
-
G, Hiçsönmez, F, Gümrük, M, Cetin, N, Ozbek, M, Tuncer, and T, Gürsel
- Subjects
Leukemia, Myeloid, Acute ,Anemia, Refractory, with Excess of Blasts ,Adolescent ,Platelet Aggregation ,Child, Preschool ,Myelodysplastic Syndromes ,Bernard-Soulier Syndrome ,Humans ,Female ,Blood Platelet Disorders ,Age of Onset - Abstract
Platelet function was studied in a child with myelodysplastic syndrome (MDS: refractory anemia with an excess of blasts) and a child with acute myeloblastic leukemia (AML-M6) associated with trilineage myelodysplasia (TMDS). An acquired Bernard-Soulier-like platelet defect was considered in both patients with the findings of prolonged bleeding time and abnormally large platelets that failed to aggregate in response to ristocetin. In contrast to findings in von Willebrand's disease, the abnormal response of platelets to ristocetin could not be corrected by the addition of normal flesh plasma. The detection of abnormal platelet aggregation response to ristocetin may be a useful diagnostic finding for clonal disorders causing impaired platelet function in MDS and coexistent TMDS associated with AML. Further studies of ristocetin-induced platelet aggregation in a large number of these patients are required.
- Published
- 1995
32. Secondary acute myeloblastic leukemia in a child with acute lymphoblastic leukemia treated with epipodophyllotoxins
- Author
-
N, Ozbek, M, Cetin, A M, Tuncer, and S, Yetgin
- Subjects
Leukemia, Myeloid, Acute ,Fatal Outcome ,Turkey ,Child, Preschool ,Sepsis ,Acute Disease ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Female ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,Etoposide - Abstract
Etoposide is a semi-synthetic, topoisomerase active podophyllotoxin derivative which frequently causes deletions and rearrangements on chromosomes 11q23 and 11q22. It can cause therapy-related, acute myeloblastic leukemia in patients receiving the drug in a schedule-dependent manner. Here we present a case with acute lymphoblastic leukemia who developed secondary acute myeloblastic leukemia 28 months after the beginning of therapy which contained etoposide on an every-other-week schedule.
- Published
- 1995
33. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes
- Author
-
G, Hiçsönmez, A M, Tuncer, T, Sayli, E, Güler, M, Cetin, N, Ozbek, and G J, Mufti
- Subjects
Male ,Adolescent ,Dose-Response Relationship, Drug ,Child, Preschool ,Myelodysplastic Syndromes ,Cytarabine ,Humans ,Drug Therapy, Combination ,Female ,Mitoxantrone ,Child ,Methylprednisolone ,Drug Administration Schedule - Abstract
High-dose methylprednisolone (HDMP) has been shown to induce differentiation of myeloid leukemic cells with a remarkable antileukemic effect in children with various subtypes of acute myeloblastic leukemia (AML), therefore we used HDMP in the treatment of four children with myelodysplastic syndrome (MDS). Two patients had refractory anemia with an excess of blasts in transformation (RAEB-t) with extramedullary infiltration (EMI), one had chronic myelomonocytic leukemia with pleural effusion, and one had RAEB. HDMP was administered orally at a single dose of 20-30 mg/kg/day combined with low-dose cytosine arabinoside (LD Ara-C) (10 mg/m2, 12-hourly s.c.) for 2 weeks. The treatment continued with mitoxantrone (10 mg/m2, i.v.) and Ara-C (5 mg/kg, i.v.) once a week for four doses followed by maintenance chemotherapy. All patients achieved hematologic remission 2-4 weeks after initiation of treatment. Extramedullary infiltration disappeared in all cases within 2 weeks to 3 months after initiation of therapy. With the exception of two patients who relapsed 6 and 24 months after remission, treatment could be stopped in others who remained in remission for 36 months without evidence of EMI; 6 months later one of them developed myelodysplastic relapse (RAEB). No side effects related to HDMP treatment were noted, but hyperleukocytosis developed in two patients who initially had high WBC counts. We suggest that the addition of HDMP with or without LD Ara-C to cytotoxic chemotherapy offers a promising alternative in cases not considered suitable for bone marrow transplantation.
- Published
- 1995
34. Acute hemolysis in association with hepatitis B infection in a child with beta-thalassemia trait
- Author
-
A, Gürgey, A, Yüce, N, Ozbek, and N, Koçak
- Subjects
Male ,Anemia, Hemolytic ,Heterozygote ,Acute Disease ,beta-Thalassemia ,Humans ,Child ,Hepatitis B ,Hemolysis - Abstract
Autoimmune hemolytic anemia may occur in the course of some viral diseases such as Coxsackie virus, cytomegalovirus, Epstein Barr virus, Influenza A, herpes simplex virus, and rarely hepatitis B virus infection. The role of being heterozygous for beta-thalassemia in hemolysis during acute viral hepatitis is not known. In this report, we present an eight-year-old boy with jaundice and anemia. The diagnosis of hepatitis B virus infection and hemolytic anemia were made on the basis of physical and laboratory findings. A hemoglobin electrophoresis revealed that the child was heterozygous for beta-thalassemia. No specific etiology could be found for hemolytic anemia. It remained unclear whether hemolytic anemia in this patient was merely a coincidental finding or whether hepatitis B virus infection and beta-thalassemia trait had played a role in causing hemolysis.
- Published
- 1994
35. Kostmann's syndrome with chronic pneumonia and lymphocytosis: effect of recombinant human G-CSF
- Author
-
S, Yetgin, N, Ozbek, M, Tuncer, A, Göçmen, and U, Ozçelik
- Subjects
Chronic Disease ,Granulocyte Colony-Stimulating Factor ,Humans ,Infant ,Female ,Lymphocytosis ,Pneumonia ,Syndrome ,Recombinant Proteins ,Agranulocytosis - Abstract
Kostmann's syndrome is a congenital disorder characterized by impairment of myeloid differentiation in bone marrow with severe absolute neutropenia. A 17-month-old girl was admitted to the hospital with complaints of recurrent skin infections since birth and severe pneumonia of the right lung which had been resistant to antibiotics since the patient was eight months old. Anemia, severe neutropenia and maturational arrest of granulocytes at the myelocyte stage in bone marrow were detected. At the age of 20 months, a right pneumonectomy was performed because of resistant cystic infection. Postoperatively, she was diagnosed with Kostmann's syndrome. Recombinant human granulocyte-colony-stimulating factor (rhG-CSF) was administered intravenously at a dose of 3 micrograms/kg/day, gradually increasing to 60 micrograms/kg/day in sequential seven-day courses to obtain a neutrophil count of more than 500 cells/mm3. Absolute neutrophil counts increased to greater than 1000 cells/mm3 at a dose of 60 micrograms/kg/day, and at that time bone marrow aspiration revealed an increase in neutrophilic granulocytic precursors beyond the myelocyte stage. In order to maintain the neutrophil response, a dose of 20 micrograms/kg/day rhG-CSF subcutaneously was continued successfully. The patient has tolerated rhG-CSF treatment without complications, and infectious attacks have significantly decreased.
- Published
- 1994
36. Osteomyelitis related to BCG vaccination: case report
- Author
-
A, Göçmen, U, Ozçelik, N, Kiper, O, Küçükosmanoğlu, and N, Ozbek
- Subjects
Tibia ,Antitubercular Agents ,BCG Vaccine ,Humans ,Infant ,Female ,Osteomyelitis ,Ulna - Abstract
A nine-month-old girl with osteomyelitis related to BCG vaccination is presented. The patient did not have any clinical evidence of immunodeficiency. Her X-ray examination showed a lytic lesion of the right tibia and of the left ulna. Histopathological examination of biopsy material revealed a chronic granulomatous inflammatory reaction. She improved with intermittent short course antituberculosis therapy.
- Published
- 1993
37. Narcissism and object relations
- Author
-
Paul J. Watson, Tracy Little, I. N. Ozbek, and Michael D. Biderman
- Subjects
Adult ,Male ,Narcissistic supply ,Psychometrics ,Adolescent ,Personality Inventory ,Personality Disorders ,Developmental psychology ,0504 sociology ,Narcissistic personality disorder ,Reference Values ,Narcissism ,medicine ,Humans ,0501 psychology and cognitive sciences ,Psychoanalytic theory ,General Psychology ,Narcissistic Personality Inventory ,Self ,05 social sciences ,050401 social sciences methods ,Middle Aged ,medicine.disease ,Object Attachment ,050106 general psychology & cognitive sciences ,Psychoanalytic Theory ,Object relations theory ,Female ,medicine.symptom ,Psychology ,Social psychology - Abstract
Questionnaire measures of the narcissistic personality disorder can predict healthy and unhealthy self-functioning. That this outcome might support Heinz Kohut's psychoanalytic psychology of the self was tested in a sample of 354 undergraduates. In canonical correlations, factors from the Narcissistic Personality Inventory were associated more strongly with grandiose than with idealizing immaturities in Kohut's bipolar self, while difficulties in interpersonal relationships (i.e., poor object relations) were associated more strongly with idealizing deficits. Zero-order and partial correlational data were congruent with Kohut's hypothesis that self-grandiosity can include elements of both “pathology” and relative mental health, but canonical correlations did not support Kohut's claim that narcissism can be described in a bidimensional self-structure.
- Published
- 1992
38. Metastasis to the Pituitary Gland From Lung Cancer
- Author
-
Unsal, Meftun, primary, Cokluk, Cengiz, additional, Turker, Hande, additional, and Okumus, Nilg??n Ozbek, additional
- Published
- 2007
- Full Text
- View/download PDF
39. Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia
- Author
-
G, Hiçsönmez, S, Ozsoylu, A M, Tuncer, G, Ertürk, N, Ozbek, and N, Karadeniz
- Subjects
Male ,Leukemia, Myeloid, Acute ,Dose-Response Relationship, Drug ,Bone Marrow ,Humans ,Cell Differentiation ,Child ,Methylprednisolone - Published
- 1991
40. Pyruvate kinase deficiency misdiagnosed as congenital dyserythropoietic anemia type i
- Author
-
A. Koca Yozgat, A. Yazal Erdem, D. Kaçar, N. Özbek, and N. Yaralı
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
41. Multiple sulfatase deficiency: A case series of four children
- Author
-
Faruk Incecik, Mehmet N Ozbek, Serdal Gungor, Stefano Pepe, Ozlem M Herguner, Neslihan Onenli Mungan, Sabiha Gungor, and Sakir Altunbasak
- Subjects
Child ,multiple sulfatase deficiency ,sulfatase-modifying factor 1 gene ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Multiple sulfatase deficiency is biochemically characterized by the accumulation of sulfated lipids and acid mucopolysaccharides. The gene sulfatase-modifying factor 1 (SUMF1), recently identified, encodes the enzyme responsible for post-translational modification of a cysteine residue, which is essential for the activity of sulfatases. We describe clinical findings and mutation analysis of four patients. The patients presented with hypotonia, developmental delay, coarse face, ichthyosis, and hepatosplenomegaly. The diagnosis was made through clinical findings, enzymatic assays, and mutation analysis. We were detected to be homozygous for a novel missense mutation c. 739G > C causing a p.G247R amino acid substitution in the SUMF1 protein.
- Published
- 2013
- Full Text
- View/download PDF
42. Who would be the winner? A prognostic nomogram for predicting the benefit of postoperative radiotherapy ± chemotherapy in patients with locally advanced gastric cancer: TROD-02-01 study.
- Author
-
Sert F, Bilkay Gorken I, Ozkok S, Colpan Oksuz D, Yucel B, Kaytan Saglam E, Aksu G, Cetin E, Aktan M, Canyilmaz E, Ozbek Okumus N, Yildirim B, Akyurek S, Serin M, Kurt M, Arican Alicikus Z, Erdis E, and Yalman D
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Prognosis, Adult, Combined Modality Therapy, Survival Rate, Stomach Neoplasms pathology, Stomach Neoplasms therapy, Stomach Neoplasms mortality, Nomograms, Gastrectomy, Neoplasm Staging
- Abstract
Objectives: We aimed to develop a basic, easily applicable nomogram to improve the survival prediction of the patients with stage II/III gastric cancer (GC) and to select the best candidate for postoperative radiotherapy (RT)., Methods: In this multicentric trial, we retrospectively evaluated the data of 1597 patients with stage II/III GC after curative gastrectomy followed by postoperative RT ± chemotherapy (CT). Patients were divided into a training set (n = 1307) and an external validation set (n = 290). Nomograms were created based on independent predictors identified by Cox regression analysis in the training set. The consistency index (C-index) and the calibration curve were used to evaluate the discriminative ability and accuracy of the nomogram. A nomogram was created based on the predictive model and the identified prognostic factors to predict 5-year cancer-specific survival (CSS) and progression-free survival (PFS)., Results: The multivariate Cox model recognized lymph node (LN) involvement status, lymphatic dissection (LD) width, and metastatic LN ratio as covariates associated with CSS. Depth of invasion, LN involvement status, LD width, metastatic LN ratio, and lymphovascular invasion were the factors associated with PFS. Calibration of the nomogram predicted both CSS and PFS corresponding closely with the actual results. In our validation set, discrimination was good (C-index, 0.76), and the predicted survival was within a 10% margin of ideal nomogram., Conclusions: In our relatively large cohort, we created and validated both CSS and PFS nomograms that could be useful for underdeveloped or developing countries rather than Korea and Japan, where the D2 gastrectomy is routinely performed. This could serve as a true map for oncologists who must make decisions without an experienced surgeon and a multidisciplinary tumor board., Competing Interests: Declaration of competing interest All authors concluded that they have not any conflict of interest., (Copyright © 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
43. Hydrophobicity Tuned Polymeric Redox Materials with Solution-Specific Electroactive Properties for Selective Electrochemical Metal Ion Recovery in Aqueous Environments.
- Author
-
Tan KJ, Morikawa S, Hemmatifar A, Ozbek N, Liu Y, and Hatton TA
- Abstract
Adaptable redox-active materials hold great potential for electrochemically mediated separation processes via targeted molecular recognition and reduced energy requirements. This work presents molecularly tunable vinylferrocene metallopolymers (P(VFc-co-X)) with modifiable operating potentials, charge storage capacities, capacity retentions, and analyte affinities in various electrolyte environments based on the hydrophobicity of X. The styrene (St) co-monomer impedes hydrophobic anions from ferrocene access, providing P(VFc-co-St) with specific response capabilities for and greatly improved cyclabilities in hydrophilic anions. This adjustable electrochemical stability enables preferential chromium and rhenium oxyanion separation from both hydrophobic and hydrophilic electrolytes that significantly surpasses capacitive removal by an order of magnitude, with a robust perrhenate uptake capacity of 329 mg/g VFc competitive with established metal-organic framework physisorbents and 17-fold selectivity over 20-fold excess nitrate. Pairing P(VFc-co-X) with other solution-specific electroactive macromolecules such as the pH-dependent poly(hydroquinone) (PHQ) and the cesium-selective nickel hexacyanoferrate (NiHCF) generates dual-functionalized electrosorption cells. P(VFc-co-X)//PHQ offers optimizable energetics based on X and pH for a substantial 4.6-fold reduction from 0.21 to 0.04 kWh/mol rhenium in acidic versus near-neutral media, and P(VFc-co-St)//NiHCF facilitates simultaneous extraction of rhenium, chromium, and cesium ions. Proof-of-concept reversible perrhenate separation in flow further highlights such frameworks as promising approaches for next-generation water purification technologies.
- Published
- 2023
- Full Text
- View/download PDF
44. Redox Polyelectrolytes with pH-Sensitive Electroactive Functionality in Aqueous Media.
- Author
-
Tan KJ, Morikawa S, Ozbek N, Lenz M, Arlt CR, Tschöpe A, Franzreb M, and Hatton TA
- Abstract
A framework of ferrocene-containing polymers bearing adjustable pH- and redox-active properties in aqueous electrolyte environments was developed. The electroactive metallopolymers were designed to possess enhanced hydrophilicity compared to the vinylferrocene (VFc) homopolymer, poly(vinylferrocene) (PVFc), by virtue of the comonomer incorporated into the macromolecule, and could also be prepared as conductive nanoporous carbon nanotube (CNT) composites that offered a variety of different redox potentials spanning a ca. 300 mV range. The presence of charged non-redox-active moieties such as methacrylate (MA) in the polymeric structure endowed it with acid dissociation properties that interacted synergistically with the redox activity of the ferrocene moieties to impart pH-dependent electrochemical behavior to the overall polymer, which was subsequently studied and compared to several Nernstian relationships in both homogeneous and heterogeneous configurations. This zwitterionic characteristic was leveraged for the enhanced electrochemical separation of several transition metal oxyanions using a P(VFc
0.63 - co -MA0.37 )-CNT polyelectrolyte electrode, which yielded an almost twofold preference for chromium as hydrogen chromate versus its chromate form, and also exemplified the electrochemically mediated and innately reversible nature of the separation process through the capture and release of vanadium oxyanions. These investigations into pH-sensitive redox-active materials provide insight for future developments in stimuli-responsive molecular recognition, with extendibility to areas such as electrochemical sensing and selective separation for water purification.- Published
- 2023
- Full Text
- View/download PDF
45. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
- Author
-
Doll MK, Waghmare A, Heit A, Levenson Shakoor B, Kimball LE, Ozbek N, Blazevic RL, Mose L, Boonyaratanakornkit J, Stevens-Ayers TL, Cornell K, Sheppard BD, Hampson E, Sharmin F, Goodwin B, Dan JM, Archie T, O'Connor T, Heckerman D, Schmitz F, Boeckh M, and Crotty S
- Subjects
- Humans, Adult, Female, Middle Aged, Male, Cohort Studies, Prospective Studies, SARS-CoV-2, COVID-19 epidemiology
- Abstract
Importance: The US arrival of the Omicron variant led to a rapid increase in SARS-CoV-2 infections. While numerous studies report characteristics of Omicron infections among vaccinated individuals or persons with previous infection, comprehensive data describing infections among adults who are immunologically naive are lacking., Objectives: To examine COVID-19 acute and postacute clinical outcomes among a well-characterized cohort of unvaccinated and previously uninfected adults who contracted SARS-CoV-2 during the Omicron (BA.1/BA.2) surge, and to compare outcomes with infections that occurred during the Delta wave., Design, Setting, and Participants: This prospective multisite cohort study included community-dwelling adults undergoing high-resolution symptom and virologic monitoring in 8 US states between June 2021 and September 2022. Unvaccinated adults aged 30 to less than 65 years without an immunological history of SARS-CoV-2 who were at high risk of infection were recruited. Participants were followed for up to 48 weeks, submitting regular COVID-19 symptom surveys and nasal swabs for SARS-CoV-2 polymerase chain reaction (PCR) testing. Data were analyzed from May to October 2022., Exposures: Omicron (BA.1/BA.2 lineages) vs Delta SARS-CoV-2 infection, defined as a positive PCR test result that occurred during a period when the variant represented at least 50% of circulating SARS-CoV-2 variants in the participant's geographic region., Main Outcomes and Measure(s): The main outcomes examined were the prevalence and severity of acute (≤28 days after onset) and postacute (≥5 weeks after onset) symptoms., Results: Among 274 participants who were immunologically naive (mean [SD] age, 49 [9.7] years; 186 [68%] female; 19 [7%] Hispanic participants; 242 [88%] White participants), 166 (61%) contracted SARS-CoV-2. Of these, 137 infections (83%) occurred during the Omicron-predominant period and 29 infections (17%) occurred during the Delta-predominant period. Asymptomatic infections occurred among 7% (95% CI, 3%-12%) of Omicron-wave infections and 0% (95% CI, 0%-12%) of Delta-wave infections. Health care use among individuals with Omicron-wave infections was 79% (95% CI, 43%-92%) lower relative to individuals with Delta-wave infections (P = .001). Compared with individuals infected during the Delta wave, individuals infected during the Omicron wave also experienced a 56% (95% CI, 26%-74%, P = .004) relative reduction in the risk of postacute symptoms and a 79% (95% CI, 54%-91%, P < .001) relative reduction in the rate of postacute symptoms., Conclusions and Relevance: These findings suggest that among adults who were previously immunologically naive, few Omicron-wave (BA.1/BA.2) and Delta-wave infections were asymptomatic. Compared with individuals with Delta-wave infections, individuals with Omicron-wave infections were less likely to seek health care and experience postacute symptoms.
- Published
- 2023
- Full Text
- View/download PDF
46. Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves.
- Author
-
Doll MK, Waghmare A, Heit A, Levenson Shakoor B, Kimball LE, Ozbek N, Blazevic RL, Mose L, Boonyaratanakornkit J, Stevens-Ayers TL, Cornell K, Sheppard BD, Hampson E, Sharmin F, Goodwin B, Dan JM, Archie T, O'Connor T, Heckerman D, Schmitz F, Boeckh M, and Crotty S
- Abstract
Importance: The U.S. arrival of the Omicron variant led to a rapid increase in SARS-CoV-2 infections. While numerous studies report characteristics of Omicron infections among vaccinated individuals and/or persons with a prior history of infection, comprehensive data describing infections among immunologically naïve adults is lacking., Objective: To examine COVID-19 acute and post-acute clinical outcomes among a well-characterized cohort of unvaccinated and previously uninfected adults who contracted SARS-CoV-2 during the Omicron (BA.1/BA.2) surge, and to compare outcomes with infections that occurred during the Delta wave., Design: A prospective cohort undergoing high-resolution symptom and virologic monitoring between June 2021 and September 2022., Setting: Multisite recruitment of community-dwelling adults in 8 U.S. states., Participants: Healthy, unvaccinated adults between 30 to 64 years of age without an immunological history of SARS-CoV-2 who were at high-risk of infection were recruited. Participants were followed for up to 48 weeks, submitting regular COVID-19 symptom surveys and nasal swabs for SARS-CoV-2 PCR testing., Exposures: Omicron (BA.1/BA.2 lineages) versus Delta SARS-CoV-2 infection, defined as a positive PCR that occurred during a period when the variant represented ≥50% of circulating SARS-CoV-2 variants in the participant's geographic region., Main Outcomes and Measures: The main outcomes examined were the prevalence and severity of acute (≤28 days post-onset) and post-acute (≥5 weeks post-onset) symptoms., Results: Among 274 immunologically naïve participants, 166 (61%) contracted SARS-CoV-2. Of these, 137 (83%) and 29 (17%) infections occurred during the Omicron- and Delta-predominant periods, respectively. Asymptomatic infections occurred among 6.7% (95% CI: 3.1%, 12.3%) of Omicron cases and 0.0% (95% CI: 0.0%, 11.9%) of Delta cases. Healthcare utilization among Omicron cases was 79% (95% CI: 43%, 92%, P =0.001) lower relative to Delta cases. Relative to Delta, Omicron infections also experienced a 56% (95% CI: 26%, 74%, P =0.004) and 79% (95% CI: 54%, 91%, P <0.001) reduction in the risk and rate of post-acute symptoms, respectively., Conclusions and Relevance: These findings suggest that among previously immunologically naïve adults, few Omicron (BA.1/BA.2) and Delta infections are asymptomatic, and relative to Delta, Omicron infections were less likely to seek healthcare and experience post-acute symptoms.
- Published
- 2022
- Full Text
- View/download PDF
47. Central Nervous System Fungal Infections in Children With Leukemia and Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study.
- Author
-
Karaman S, Kebudi R, Kizilocak H, Karakas Z, Demirag B, Evim MS, Yarali N, Kaya Z, Karagun BS, Aydogdu S, Caliskan U, Ayhan AC, Bahadir A, Cakir B, Guner BT, Albayrak C, Karapinar DY, Kazanci EG, Unal E, Turkkan E, Akici F, Bor O, Vural S, Yilmaz S, Apak H, Baytan B, Tahta NM, Güzelkucuk Z, Kocak U, Antmen B, Tokgöz H, Fisgin T, Özdemir N, Gunes AM, Vergin C, Unuvar A, Ozbek N, Tugcu D, Bay SB, Tanyildiz HG, and Celkan T
- Subjects
- Child, Humans, Retrospective Studies, Antifungal Agents therapeutic use, Hematopoietic Stem Cell Transplantation adverse effects, Hematopoietic Stem Cell Transplantation methods, Invasive Fungal Infections diagnosis, Invasive Fungal Infections drug therapy, Invasive Fungal Infections etiology, Central Nervous System Fungal Infections diagnosis, Central Nervous System Fungal Infections therapy, Leukemia drug therapy
- Abstract
Background: Central nervous system fungal infections (CNSFI) are seen in patients with hematologic malignancies and have high morbidity and mortality. Because of their rarity, there is limited data on CNSFI in children with no established treatment protocols or guidelines., Materials and Methods: In this multicenter retrospective study, 51 pediatric patients with leukemia, 6 of whom had undergone bone marrow transplantation, with proven or probable CNSFI were evaluated. Fungal infections were defined as proven or probable based on European Organisation for Research and Treatment of Cancer criteria. Proven CNSFI was diagnosed by appropriate central nervous system (CNS) imaging or tissue sample findings in combination with positive microbiological results of cerebrospinal fluid. A positive culture, microscopic evidence of hyphae, a positive result of the galactomannan assays are defined as positive microbiological evidence. Probable CNSFI was defined as appropriate CNS imaging findings together with proven or probable invasive fungal infections at another focus without CNS when there is no other explanatory condition. Data was collected by using the questionnaire form (Supplemental Digital Content 1, http://links.lww.com/JPHO/A541 )., Results: Seventeen patients had proven, 34 patients had probable CNSFI. Headaches and seizures were the most common clinical findings. The median time between the onset of fever and diagnosis was 5 days. The most common fungal agent identified was Aspergillus . Sixteen patients received single-agent, 35 received combination antifungal therapy. Surgery was performed in 23 patients. Twenty-two patients (43%) died, 29 of the CNSFI episodes recovered with a 20% neurological sequelae., Conclusion: CNSFIs should be considered in the differential diagnosis in patients with leukemia and refractory/recurrent fever, headache, neurologicalocular symptoms, and a radiologic-serological evaluation should be performed immediately. Early diagnosis and prompt management, both medical and surgical, are essential for improving clinical outcomes., Competing Interests: The authors declare no conflict of interest.
- Published
- 2022
- Full Text
- View/download PDF
48. Electrochemically Mediated Direct CO 2 Capture by a Stackable Bipolar Cell.
- Author
-
Hemmatifar A, Kang JS, Ozbek N, Tan KJ, and Hatton TA
- Subjects
- Carbon, Electrodes, Temperature, Atmosphere, Carbon Dioxide chemistry
- Abstract
The unprecedented increase in atmospheric CO
2 concentration calls for effective carbon capture technologies. With distributed sources contributing to about half of the overall emission, CO2 capture from the atmosphere [direct air capture, (DAC)] is more relevant than ever. Herein, an electrochemically mediated DAC system is reported which utilizes affinity of redox-active quinone moieties towards CO2 molecules, and unlike incumbent chemisorption technologies which require temperature or pH swing, relies solely on the electrochemical voltage for CO2 capture and release. The design and operation of a DAC system is demonstrated with stackable bipolar cells using quinone chemistry. Specifically, poly(vinylanthraquinone) (PVAQ) negative electrode undergoes a two-electron reduction reaction and reversibly complexes with CO2 , leading to CO2 sequestration from the feed stream. The subsequent PVAQ oxidation, conversely, results in release of CO2 . The performance of both small- and meso-scale cells for DAC are evaluated with feed CO2 concentrations as low as 400 ppm (0.04 %), and energy consumption is demonstrated as low as 113 kJ per mole of CO2 captured. Notably, the bipolar cell construct is modular and expandable, equally suitable for small and large plants. Moving forward, this work presents a viable and highly customizable electrochemical method for DAC., (© 2022 The Authors. ChemSusChem published by Wiley-VCH GmbH.)- Published
- 2022
- Full Text
- View/download PDF
49. Redox-Active Magnetic Composites for Anionic Contaminant Removal from Water.
- Author
-
Tan KJ, Morikawa S, Phillips KR, Ozbek N, and Hatton TA
- Abstract
Global water security is jeopardized by the presence of anthropogenic contaminants, which can persist resiliently in the environment and adversely affect human health. Surface adsorption of polluting species is an effective technique for water purification. In this work, redox-active magnetic compounds were designed for the targeted removal of inorganic and organic anions in water via polymeric redox-active vinylferrocene (VFc) and pyrrole (Py) moieties. An Fe
3 O4 @SiO2 @PPy@P(VFc- co -HEMA) composite was prepared in a four-step process, with the outermost layer possessing heightened hydrophilicity as a result of the optimized incorporation of 2-hydroxyethylmethacrylate (HEMA) monomers into the backbone of the ferrocene macromolecule. The synthesized materials are able to separate carcinogenic hexavalent chromium oxyanions and other charged micropollutants, and exhibit a 2-fold or greater enhancement in adsorption uptake once the redox-active ferrocene groups are oxidized to ferrocenium cations, with capacities of 23, 49, 66, and 95 mg/g VFc for maleic acid, 2-(6-methoxy-2-naphthyl)propionic acid (Naproxen), (2,4-dichlorophenoxy)acetic acid (2,4-D), and (2-dodecylbenzene)sulfonic acid (DBS), respectively, and a > 99% extractability of chromium in the 1 ppm range. The application of redox-active components to a magnetic particulate scaffold improves maneuverability and phase contact, giving rise to new potential aqueous separation process frameworks for water or product purification.- Published
- 2022
- Full Text
- View/download PDF
50. Understanding Material Compatibility in CO 2 Capture Systems Using Molten Alkali Metal Borates.
- Author
-
Halliday C, Ozbek N, and Hatton TA
- Abstract
Molten alkali metal borates have been proposed as energy-efficient sorbents for the low-cost capture of CO
2 at high temperatures. The molten sorbents could help to mitigate global warming by capturing CO2 from industrial sources and preventing the release of CO2 into the atmosphere. However, these novel materials operate under harsh conditions, introducing challenges of which material compatibility is one of the most important. Other than platinum, where a less than 0.1% change in performance was observed over 1000 h of continuous use, few materials were found to be compatible with the molten salts. Common ceramics, steels, and superalloys were eliminated from consideration due to corrosive oxidation of the substrate and contamination of the melt resulting in chemical degradation and reduction in the sorbent's working capacity. A high-purity nickel alloy, Nickel 200/201, with a protective oxide layer was found to perform optimally with regards to both corrosive degradation and chemical degradation. Modest corrosion rates on the order of 0.3-0.5 mm/year were estimated, and the sorbent capacity was found to drop by between a manageable 0.5 and 20% over 100 h. Various protective measures are proposed, and future work suggested, to ensure that material compatibility does not limit the potential of molten alkali metal borates to reduce CO2 emissions and contribute to a clean energy future.- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.